# Islet Transplantation Using PKX-001

> **NCT03073577** · PHASE1 · COMPLETED · sponsor: **University of Alberta** · enrollment: 18 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Antiaging Glycopeptide

## Key facts

- **NCT ID:** NCT03073577
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-17
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-05-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073577, "Islet Transplantation Using PKX-001". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03073577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*